AnnexMedAnnexMedAnnexMed
Corporate Office
USA
299 S. Main Street
Suite 1300
Salt Lake City, UT 84111
Chennai - Tower I
CeeDeeYes Tyche Towers,
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
Chennai - Tower II
4th Floor, IIFL TOWERS
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram
No 9, Viswalingam Layout
Villupuram,
Tamil Nadu – 605602

Hematology Revenue Cycle Management

End-to-End Billing for Blood Disorders, Diagnostics, and Complex Hematology Care

Comprehensive coding, billing, and revenue cycle management across CBC panels, bone marrow procedures, transfusion services, buy-and-bill drug management, infusion administration, and multi-service hematology encounters — for every clinical setting.

97%+

Clean Claim Rate

22-32%

Revenue Increase

28-38%

A/R Days Reduction

2-3 Wks

Implementation

Diagnostic-driven. Procedure-intensive. Precision-billed.

Hematology billing sits at the intersection of diagnostic-driven care, laboratory-intensive workflows, and procedure-based revenue — making it one of the most technically demanding specialties in revenue cycle management. Practices treating blood disorders, hematologic malignancies, and coagulation conditions face revenue leakage from missed lab interpretation codes, improperly sequenced infusion billing, J-code unit calculation errors, underbilled bone marrow procedures, and high denial rates tied to documentation gaps on multi-service encounters. Because hematology inherently generates multiple billable services per patient visit — diagnostics, procedures, infusions, and E&M — each billing gap compounds across the full treatment relationship.

AnnexMed specializes in comprehensive RCM for hematology providers including general hematologists, hematology-oncologists, benign hematology specialists, transfusion medicine physicians, and coagulation disorder specialists. Our certified coders and billing experts understand the full hematology billing landscape: chemotherapy and drug administration coding (96401-96549), J-code drug billing for Rituxan, Neulasta, and clotting factors, bone marrow aspiration and biopsy (38220-38222), therapeutic apheresis (36511-36516), blood transfusion services (36430), and the documentation precision required to support medical necessity across every payer. We manage everything from insurance verification and prior authorization through denial management and payment posting — optimizing revenue across the complete hematology care cycle.

Aboutus-Inner-1

Trusted by 100+ healthcare providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II

soc

Why hematology billing is complex?

Hematology reimbursement creates unique billing challenges across diagnostics, multi-service encounters, high-cost drug management, and procedure-intensive workflows — each requiring specialty-specific expertise to execute accurately.

Buy-and-Bill Drug Management

Inventory management, J-code selection, unit calculations, and wastage documentation for high-cost specialty medications including Rituxan, Neulasta, IVIG, and clotting factors — with procurement coordination and payer reimbursement optimization built into every workflow.

Chemotherapy Administration Sequencing

Time-based and hierarchical coding for drug administration requires proper sequencing of initial infusions (96413), additional hours (96415), concurrent infusions (96417), and injection-only chemotherapy (96401) — with precise time documentation supporting every claim.

Bone Marrow Procedure Coding

Precise code selection between aspiration alone (38220), biopsy alone (38221), and combined procedures (38222) — one of the highest-frequency hematology billing errors. Double-billing 38220 + 38221 instead of 38222 is a leading cause of bundling denials and compliance exposure.

Prior Authorization for Specialty Drugs

Extensive pre-approval requirements for factor concentrates, IVIG, biologics, immunotherapy agents, and specialty anticoagulants create cash flow delays when PA management is reactive rather than proactive — with denial rates rising sharply when clinical documentation is incomplete.

Multi-Service Encounter Billing

Hematology visits frequently generate multiple billable services on the same date — lab tests, bone marrow procedures, infusions, and E&M — requiring precise modifier management, sequencing validation, and bundling analysis to prevent claim rejections and underpayments.

Drug Wastage Documentation

Proper billing for unused portions of single-use vials using the JW modifier requires detailed documentation capturing the amount administered, the amount wasted, and the NDC number — an area where most practices leave significant reimbursement uncaptured.

Transfusion and Blood Component Billing

Separate coding for red cell transfusion (36430), platelet administration, plasma, irradiation, and leukoreduction services per encounter — with the administration code, the blood product itself, and any processing services requiring individual claim components to capture complete reimbursement.

ICD-10 Diagnostic Precision

Precise differentiation between iron deficiency anemia (D50.x), anemia of chronic disease (D63.x), leukemia subtypes (C91.x-C95.x), coagulation defects (D68.x), and polycythemia (D45) directly impacts medical necessity, reimbursement accuracy, and risk adjustment across the full patient population.

Core RCM services

The following nine core services are included as part of AnnexMed’s standard RCM offering for every medical specialty. These services form the foundation of a high-performing revenue cycle and are customized to each specialty’s payer mix, billing codes, and documentation standards.

Eligibility & Benefits Verification

We confirm patient insurance coverage, deductibles, co-pays, and in/out-of-network status before every encounter — including specialty drug coverage and benefit verification for infusion and buy-and-bill hematology services.

Prior Authorization Management

Our team handles the full prior auth lifecycle — submission, follow-up, peer-to-peer support, and appeals — ensuring chemotherapy drugs, specialty biologics, clotting factors, and infusion therapies are pre-approved before service delivery.

Claims Submission & Tracking

We submit clean claims electronically to all payers and monitor each claim through its entire lifecycle, catching sequencing errors, bundling issues, and documentation gaps before they result in rejections.

Denial Management & Appeals

Every denied claim is reviewed, root-cause analyzed, and appealed with supporting documentation — including drug administration records, time logs, and medical necessity letters specific to hematology payer denial patterns.

Accounts Receivable (AR) Follow-up

Our AR specialists proactively follow up on outstanding balances — including high-value drug claims and infusion services — keeping days in AR below industry benchmarks across complex hematology practice environments.

Patient Statements & Collections

We manage the complete patient billing experience from clear statements to respectful collection follow-up — improving collections while preserving the patient relationships that long-term blood disorder management requires.

Payment Posting & Reconciliation

All insurance and patient payments are posted accurately and reconciled daily against expected reimbursements — including ASP-based drug reimbursement verification and contractual adjustment validation per encounter.

Provider Credentialing

We manage provider enrollment and credentialing with all commercial, Medicare, and Medicaid payers — keeping your contracts active and preventing credentialing-related delays on high-value hematology claims.

Reporting & Analytics Dashboard

Real-time RCM performance dashboards covering collections, denial rates, AR aging, drug billing metrics, authorization status, and payer-specific trends — updated daily through data & analytics platform.

Specialty-Specific RCM services

Chemotherapy Administration Billing (CPT 96401-96549)

Chemotherapy billing requires careful hierarchical sequencing of the primary infusion code (96413 for the first hour) with add-on codes for additional hours (96415), concurrent infusions (96417), and injection-only chemotherapy (96401) — with precise time documentation supporting every claim. We manage chemotherapy infusion billing with the time-based documentation protocols required to maximize reimbursement and withstand payer audits.

Blood Transfusion & Component Therapy Billing (CPT 36430, 36440, 36450)

Blood product administration billing involves separate codes for red cell transfusion (36430), platelet transfusion, plasma administration, and each blood product type — with additional billing for irradiation, leukoreduction, and the blood product itself through the facility or hospital. We ensure complete blood component billing is captured for every transfusion event, including administration, product, and processing codes.

Bone Marrow Biopsy & Aspiration Billing (CPT 38220, 38221, 38222)

Bone marrow procedures may involve aspiration alone (38220), biopsy alone (38221), or both combined (38222) — with code selection based on the documented procedure and frequent denials when the combination code is not used when both are performed. We code bone marrow procedures accurately from the procedure documentation, preventing the most common bone marrow billing error of double-billing 38220 and 38221 when 38222 should be used.

Buy-and-Bill Drug & J-Code Billing (J-codes, JW Modifier)

Hematology practices using the buy-and-bill model for drugs like Neulasta, Rituxan, and IVIG must balance drug acquisition cost recovery through J-code billing against payer reimbursement rates, prior authorization requirements, and wastage documentation. We manage full-cycle buy-and-bill drug billing — procurement coordination, J-code selection, unit verification, wastage documentation with JW modifier, and ASP pricing reconciliation.

Coagulation & Bleeding Disorder Billing (D66, D67, D68.x)

Billing for hemophilia, von Willebrand disease, and other coagulation disorders involves complex factor replacement therapy administration billing, clotting factor product J-code billing, and home infusion program management with separate professional and facility components. We manage the specialized billing requirements for bleeding disorder treatment across every care setting and payer type.

Stem Cell Transplant Coordination Billing (CPT 38240-38243)

Hematopoietic stem cell transplant billing is a multi-episode billing process covering donor and recipient mobilization, the transplant procedure (38240-38242), and post-transplant monitoring — each with distinct coding and documentation requirements across long claim cycles. We coordinate stem cell transplant billing across the complete care episode, ensuring every phase generates appropriate reimbursement.

Apheresis & Therapeutic Phlebotomy Billing (CPT 36511-36516, 99195)

Therapeutic apheresis and phlebotomy are frequently performed in hematology practices for conditions like polycythemia vera and hyperviscosity syndrome, generating per-procedure revenue when correctly billed with diagnosis codes that meet payer coverage criteria. We ensure apheresis procedures are billed with the correct CPT and ICD-10 pairings required for each therapeutic indication.

Lab Interpretation & Hematopathology Billing (Professional Component)

Hematologists providing professional interpretation of peripheral blood smears, bone marrow biopsies, flow cytometry studies, and coagulation panels can bill for these interpretive services separately from the technical component — revenue that most practices consistently leave uncaptured. We identify and bill all hematopathology interpretation services, closing the professional component billing gap.

ICD-10 Coding (D50.x, C91.x-C95.x, D68.x Series)

Hematology ICD-10 coding requires precise differentiation between iron deficiency anemia (D50.x), anemia of chronic disease (D63.x), leukemia subtypes (C91.x-C95.x), coagulation defects (D68.x), polycythemia vera (D45), and thrombocytopenia (D69.x) — with each combination directly affecting medical necessity, reimbursement, and risk adjustment accuracy. Our certified hematology coders ensure every claim reflects the full diagnostic complexity of your patients.

Hematology RCM modules

AnnexMed’s hematology platform deploys six specialty-built modules addressing the highest-impact revenue and compliance risks across buy-and-bill drug management, infusion administration, bone marrow procedures, and multi-service diagnostic billing.

Buy-and-Bill Drug Management Engine

Manages specialty drug procurement coordination, J-code selection and validation, unit calculation verification, wastage documentation with JW modifier, and ASP pricing reconciliation — protecting the highest-value revenue stream in hematology practices managing buy-and-bill medications.

Infusion & Administration Sequencing Validator

Automated hierarchical coding review for chemotherapy and drug administration — ensuring proper sequencing of initial, concurrent, sequential, and add-on infusion codes per encounter, with time-based documentation verification across all 96000-series billing.

Bone Marrow & Procedure Coding Auditor

Pre-submission review of bone marrow and hematology procedure codes to prevent combination code errors (38220 + 38221 vs. 38222), modifier omissions, and bundling denials — with procedure note cross-referencing built into the audit workflow.

Specialty Drug Prior Authorization Manager

End-to-end PA management for factor concentrates, IVIG, biologics, immunotherapy agents, and specialty anticoagulants — with clinical documentation packaging, payer portal submission, status tracking, peer-to-peer scheduling, and appeal escalation.

ICD-10 Hematology Diagnostic Validator

Automated cross-reference of diagnosis codes against treatment and procedure claims — ensuring full medical necessity support across D-series blood disorder codes, C-series malignancy codes, and coagulation defect coding to prevent diagnostic specificity denials.

Denial Intelligence Dashboard

Real-time denial tracking, root-cause categorization, and appeal workflow management with hematology-specific denial pattern analysis — surfacing trends by payer, CPT code, and denial reason through ImpactRCM.AI analytics.

Hematology billing quick reference

Service Category
Key CPT / HCPCS Codes
Common ICD-10
Top Denial Reason
AnnexMed Solution
Chemotherapy Infusion

96413, 96415, 96417, 96401

C91.x-C95.x, D64.9

Sequencing errors, missing time documentation

Hierarchical coding with time protocols

Bone Marrow Biopsy

38220, 38221, 38222

C91.x, C90.0x, D46.x

Incorrect combination code used

Procedure-specific documentation review

Blood Transfusion

36430, 36440, 36450

D50.x, D56.x, D64.x

Missing blood product component codes

Complete component billing capture

Buy-and-Bill Drugs

J9310, J9999, J0897, J0490

C83.x, D69.3, D66

Unit miscalculation, missing authorization

Unit-verified J-code billing management

Therapeutic Apheresis

36511, 36512, 36513, 36514

D45, D58.x, D89.1

Missing medical necessity documentation

Diagnosis-linked procedure billing

Coagulation Testing

85730, 85610, 86900

D68.x, D66, D67

Bundling errors, missing professional component

Unbundled lab interpretation billing

Hematology E&M

99213-99215, 99417

D50.9, C91.0, D68.9

Incomplete MDM documentation

Documentation-complete charge capture

Stem Cell Transplant

38240, 38241, 38242

C91.0x, C92.0x, C90.0x

Phase coding errors, missing episode docs

Episode-based transplant billing

Outcomes when you partner with AnnexMed

22-32%

Increase in Collections

97%+

Clean Claim Rate

80-88%

Denial Overturn Rate

28-38%

A/R Days Reduction

95%+

Drug Wastage Capture

15-20 hrs/wk

Per-Provider Time Reclaimed

What sets AnnexMed apart?

Hematology-Specific Expertise

Dedicated coders trained in the full hematology billing landscape — chemotherapy administration, bone marrow procedures, J-code drug billing, transfusion services, and hematopathology interpretation — with no generalist coding on your claims.

Buy-and-Bill Drug Mastery

Complete drug procurement tracking, J-code billing, unit verification, wastage documentation with JW modifier, and ASP pricing reconciliation — protecting the highest-value revenue stream in buy-and-bill hematology practices.

Multi-Service Encounter Expertise

Specialized billing management for same-day encounters combining diagnostics, procedures, infusions, and E&M — with modifier precision and bundling analysis that prevents the most common hematology claim rejections.

Prior Authorization Excellence

Dedicated PA team managing specialty drug authorizations for clotting factors, IVIG, biologics, and immunotherapy — with clinical documentation support, payer-specific submission, and persistent follow-up that cuts approval timelines significantly.

AI Agents & Intelligent Automation + Data & Analytics Platform

AI-powered revenue cycle automation and business intelligence delivering real-time visibility into denial patterns, AR aging, drug billing accuracy, payer contract performance, and authorization status across your hematology practice.

Data & Analytics Platform

97%+ clean claim rates and 22-32% revenue increases delivered consistently across hematology, hematology-oncology, and blood disorder practices through specialty-specific coding, proactive authorization management, and aggressive denial recovery.

Scalable Service Model

From solo hematologists and small group practices to hospital-based infusion centers and academic medical center hematology divisions — we scale services to match your patient volume and billing complexity.

Full Compliance Framework

SOC 2 Type II certified, HIPAA-compliant operations with AAPC and AHIMA credentialed coders, quarterly drug administration policy reviews, and ASP pricing monitoring to keep your practice audit-ready at all times.

user-bg

Partner with hematology RCM specialists

From buy-and-bill drug management and chemotherapy infusion billing to bone marrow procedures and transfusion services, AnnexMed optimizes every revenue stream in your hematology practice. Our certified coders and RCM specialists deliver the specialty-specific expertise that blood disorder care demands.

Frequently Asked Questions

Most hematology practices are fully operational within 2-3 weeks. We handle credentialing verification, system integration, drug billing setup, and historical data transfer with minimal disruption.
We integrate with all major hematology and oncology practice management systems. Our team has extensive experience with Epic, Cerner, Flatiron, iKnowMed, and specialty infusion center platforms.
Yes, we manage the complete buy-and-bill cycle including drug procurement coordination, inventory tracking, proper J-code billing, unit calculations, and wastage documentation.
Our team monitors quarterly ASP updates from CMS, tracks HCPCS code additions and deletions, participates in hematology billing webinars, and maintains relationships with specialty pharmacies and distributors.
We maintain an 80-88% overturn rate on appealed hematology claims through proper drug administration documentation, medical necessity justification, and payer-specific appeal strategies.
Absolutely. We'll conduct an A/R audit focusing on high-value drug claims and infusion services, identify collectible balances, develop a recovery strategy, and work outstanding claims while starting fresh.
Yes, prior authorization is a core service. We submit PA requests for factor concentrates, IVIG, specialty anticoagulants, biologics, and chemotherapy with complete clinical documentation and persistent follow-up.
You'll have 24/7 access to our secure portal with real-time dashboards showing claims status, payments, denials, drug administration metrics, authorization tracking, A/R aging, and detailed financial analytics.
We expertly manage billing across all settings including office-based infusions, hospital-based infusion centers, and coordinated care with proper place of service coding.
Yes, we have comprehensive expertise across all hematology services including benign blood disorders (anemia, thrombocytopenia, coagulation disorders) and hematologic malignancies (leukemia, lymphoma, myeloma).

Case Studies

See the impact we deliver

Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.

Client Voices

See how our clients succeed

Hear from organizations that trust AnnexMed to reduce denials, accelerate reimbursements, and strengthen cash flow. Our expert support delivers measurable performance gains, operational efficiency, financial stability, and scalable growth.
AnnexMed corrected our J-code billing across buy-and-bill medications. Drug reimbursement accuracy jumped 38% in 90 days. They handle multi-drug infusion complexity better than any RCM partner we have used.
Anx Image

Dr. Nathan Reyes

Midwest Blood & Cancer Center
We were missing revenue from bone marrow combination code errors. AnnexMed identified 22% of claims billed incorrectly and recovered over $180K in the first quarter alone.
Anx Testimonial

Sandra Kim

Regional Oncology & Hematology Group
Prior auth delays for factor concentrates were crushing our cash flow. AnnexMed cut approval timelines from 12 days to 4 days. Our denial rate dropped 44% in the first six months.
Anx Testimonial

Marcus Webb

Comprehensive Blood Disorder Clinic

Proven RCM expertise. Delivered at scale.

For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.

Certification

Want to talk to our RCM experts?

    AnnexMed Logo
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.